Table 1 Participants’ Characteristics According to the BADL and IADL dependence

Phase angle

5.41 ± 0.97

4.38 ± 0.92

< 0.001

5.62 ± 0.90

4.58 ± 0.92

< 0.001

Age, yr

59.56 ± 12.52

66.46 ± 14.11

0.002

56.35 ± 12.36

67.62 ± 11.30

< 0.001

Female, n (%)

63 (33.7)

14 (28.0)

0.445

43 (30.9)

34 (34.7)

0.543

BMI, kg/m²

22.68 ± 3.71

21.97 ± 3.37

0.202

22.84 ± 3.76

22.09 ± 3.45

0.111

Hypertension, n (%)

153 (81.8)

45 (90.0)

0.166

112 (80.6)

86 (87.8)

0.142

Diabetes, n (%)

74 (39.6)

23 (46.0)

0.411

52 (37.4)

45 (45.9)

0.190

Dialysis vintage, yr

2.62 (1.21–5.05)

1.92 (1.04–4.48)

0.140

2.65 (1.12–5.04)

2.31 (1.23–4.58)

0.546

Smoking, n (%)

0.225

0.018

 Never

91 (48.7)

18 (36.0)

65 (46.8)

44 (44.9)

 Former

54 (28.9)

20 (40)

35 (25.2)

39 (39.8)

 Current

42 (22.5)

12 (24)

39 (28.1)

15 (15.3)

Drinking, n (%)

0.401

0.761

 Never

94 (50.3)

24 (48.0)

72 (51.8)

46 (46.9)

 Former

67 (35.8)

22 (44.0)

50 (36.0)

39 (39,8)

 Current

26 (13.9)

4 (8.0)

17 (12.2)

13 (13.3)

Hemoglobin, g/L

110.7 ± 15.8

104.6 ± 18.7

0.020

110.1 ± 15.8

108.4 ± 17.8

0.433

Serum Albumin, g/L

41.8 ± 3.7

38.7 ± 5.4

< 0.001

41.8 ± 3.6

40.1 ± 5.1

0.003

BADL score

12.0(12.0–12.0)

11.0(9.0–11.0)

< 0.001

12.0(6.0–14.0)

12.00 (11.0–12.0)

< 0.001

IADL score

16.0 (15.0–16.0)

8.0 (5.0–13.0)

< 0.001

16.0 (16.0–16.0)

12.0 (6.0–14.0)

< 0.001